These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36143899)

  • 1. Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report.
    Kosmidis CS; Mystakidou CM; Koimtzis G; Papadopoulou E; Theodorou V; Katsios NI; Georgakoudi E; Sevva C; Charalampous I; Varsamis N; Koulouris C; Michael C; Papadopoulos K; Anthimidis G; Baka S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
    Karki NR; Arfa AS; Savage N; Kutlar A
    Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases.
    Kojima M; Nakamura N; Tsukamoto N; Otuski Y; Shimizu K; Itoh H; Kobayashi S; Kobayashi H; Murase T; Masawa N; Kashimura M; Nakamura S
    Int J Surg Pathol; 2008 Oct; 16(4):391-8. PubMed ID: 18499694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
    González García A; Fernández-Martín J; Robles Marhuenda Á
    Rheumatology (Oxford); 2023 Apr; 62(4):1426-1435. PubMed ID: 35997567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
    Chen H; Ba W; Chen H; Yang H
    J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric Castleman disease presenting as a chylous pleural effusion.
    Epstein D; Zohar Y; Ovadya D; Ammouri H; Kremer R; Lavi N; Tzoran I; Andrawas ER; Klein E; Miller A
    Pathol Res Pract; 2020 Nov; 216(11):153209. PubMed ID: 32950896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of Castleman Disease.
    Wu D; Lim MS; Jaffe ES
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal Castleman disease in pediatrics: case report.
    Baserga M; Rosin M; Schoen M; Young G
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease?
    Drissi M; Dunlap R; Clayton L; Raess PW; Mengden Koon S; White K
    Am J Dermatopathol; 2022 Apr; 44(4):294-296. PubMed ID: 34966045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Castleman disease of plasma cell type accompanied with bronchiolitis obliterans: a case report and review of the literature.
    Zhu Q; Wang S
    J Med Case Rep; 2023 Dec; 17(1):539. PubMed ID: 38082371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and systemic plasmacytosis in an Asian male born in the North American continent: a controversial entity potentially related to multicentric Castleman disease.
    Shadel BN; Frater JL; Gapp JD; Hurley MY
    J Cutan Pathol; 2010 Jun; 37(6):697-702. PubMed ID: 19614735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomeruloid hemangioma associated with TAFRO syndrome.
    Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
    Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castleman disease of the neck: A case report.
    Pasha H; Siddiqui MI; Wasif M
    J Pak Med Assoc; 2020 Feb; 70(2):354-356. PubMed ID: 32063646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Manifestations of Castleman Disease: Histopathological Characteristics and Review of Literature.
    Zapata-Salazar NA; Gómez-Flores M; Ocampo-Candiani J; Chavez-Alvarez S
    Am J Dermatopathol; 2021 Dec; 43(12):926-931. PubMed ID: 33989215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.